Figure 2
From: Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis
Kaplan–Meier curves of progression-free survival (PFS), based on (a) the largest diameter (mm; RECIST 1.1), (b) the largest biperpendicular diameters (mm2, RANO), or (c) clinical criteria where progression is defined as new symptom attributable to the meningioma, or initiation of treatment. For patients with multiple meningiomas, only the dominant lesion was included in the measurement. Vertical lines represent censored cases.
